獸醫輔助生殖技術市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、動物種類、受孕方法、分銷管道、地區和競爭格局分類，2021-2031年

全球獸醫輔助生殖技術市場預計將從 2025 年的 26.9 億美元成長到 2031 年的 40.8 億美元，複合年成長率為 7.21%。

該領域涵蓋多種臨床操作和生物學技術，這些技術對於促進和控制動物繁殖至關重要，包括人工授精、體外受精和胚胎移植。市場成長的主要驅動力是全球對優質動物蛋白日益成長的需求，以及透過基因改造提高牲畜生產力和抗病能力的需求。此外，為確保糧食安全而推廣的永續育種方式也推動了相關技術在酪農和肉牛產業的廣泛應用。

儘管存在這些成長要素，但高昂的營運成本和先進繁殖技術所需的專業獸醫技能構成了重大障礙，限制了小規模生產者獲得這些技術的機會。經濟現實往往將這些先進解決方案限制在大規模經營者手中。為了凸顯該行業的韌性以及對遺傳材料的持續投資，美國國家牛育種者協會在2024年報告稱，美國牛精液行業的總銷量將成長4%，達到約6900萬份。這表明，儘管某些細分市場存在財務障礙，但商業活動仍在繼續。

市場促進因素

全球對優質動物性蛋白質和乳製品的需求不斷成長，是獸醫輔助生殖技術市場的主要驅動力。隨著人口成長對食品供應鏈帶來更大壓力，生產者正在加速採用生殖技術，以最大限度地提高畜群效率和總產量。這種需求推動了人工授精和胚胎移植等技術的廣泛應用，這些技術有助於傳播優良的遺傳性狀，從而提高肉質和牛奶產量。美國農業部海外農業局在2024年4月的報告中預測，全球牛肉產量將達到5,950萬噸，這印證了上述趨勢，並強調了製定高效育種通訊協定以滿足消費目標的迫切性。

市場發展也得益於先進基因體學和胚胎學技術的快速整合，這些技術能夠精準控制牲畜的性狀。諸如性別分選精液和基因組選擇等創新技術，使獸醫專業人員能夠以極高的精度降低遺傳疾病的發生率並最佳化畜群組成。這種向精準育種的轉變是由策略性研究投資所推動的。例如，2024年6月，美國國家食品與農業研究所宣布津貼600萬美元，用於支持定量遺傳學方法的研究。這些技術進步也得到了穩健的商業性表現的支持，Genus PLC公司2024年的年收入達到6.688億英鎊，這反映了該領域巨大的經濟規模。

市場挑戰

先進生殖技術高昂的營運成本以及對專業獸醫知識的需求，是全球獸醫輔助生殖技術市場成長的主要障礙。這些經濟和技術要求造成了市場分層格局，技術的應用主要局限於資金雄厚的產業整合企業。小規模生產者往往難以證明投資報酬的合理性，而胚胎移植等技術也往往只限於優質種畜。因此，這種排他性阻礙了該技術在整個畜牧業的大規模應用。

這些障礙的具體影響體現在傳統市場領域的萎縮，而這些領域通常更容易被不同規模的生產者所進入。根據國際胚胎技術協會（IETS）2024年的統計報告，全球活體牛的採集數量較去年同期下降了6.3%，其中美國的降幅尤為顯著，高達29.8%。這一特定操作數量的下降趨勢表明，持續的經濟壓力和所需的技術水平仍然阻礙著生殖技術在該行業內的更廣泛應用。

市場趨勢

在牛育種領域，目前正經歷著從體內胚胎採集（MOET）到體外胚胎生產（IVP）的關鍵結構性轉變。這是因為IVP能夠最佳化供體產量，並利用處於不同生理狀態的母牛。該技術允許在牛干擾懷孕的情況下從妊娠牛身上採集卵子，與傳統的沖洗法相比，能夠顯著提高從優質個體中獲得的遺傳物質數量。隨著實驗室擴大規模以滿足日益成長的需求，美國胚胎移植協會（AETA）的《2025年統計委員會報告》指出，2024年美國體外受精胚胎（IVP）的產量將同比成長6.6%，達到1,037,095個，這證實了IVP已成為主流的胚胎生產方法。

同時，酪農正積極推廣性別分選精液的標準化使用，以改善牛群管理。性別分選精液用於生產後備母牛，而其餘牛群則與牛配種。這種「肉牛導向型酪農養殖」策略使生產者能夠加速乳牛群的遺傳改良，生產高價值的雜交牛供應肉牛市場，並有效抑制低價值牛的產生。這一商業性趨勢顯著改變了銷售結構。 2025年3月，美國國家畜牧育種者協會報告稱，性別分選乳牛精液將成為美國最大的產品類型，到2024年銷售量將達到990萬單位。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸醫輔助生殖技術市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（普通精液、性別分選精液）
  • 動物種類（牛、豬、羊、山羊、馬、其他動物）
  • 透過受精方法（人工授精、胚胎移植、體外受精）
  • 通路（私營部門、公共機構）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美獸醫輔助生殖技術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲獸醫輔助生殖技術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區獸醫輔助生殖技術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲獸醫輔助生殖技術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲獸醫輔助生殖技術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球獸醫輔助生殖技術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Genus Plc
• URUS Group LP
• CRV Holding BV
• Semex USA Inc.
• Select Sires, Inc.
• Swine Genetics International Ltd.
• Inguran Sorting Technologies LLP
• Viking Genetics Fmba
• Geno SA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Veterinary Assistive Reproduction Technology Market is projected to expand from a valuation of USD 2.69 Billion in 2025 to USD 4.08 Billion by 2031, reflecting a compound annual growth rate of 7.21%. This sector encompasses various clinical procedures and biological techniques, such as artificial insemination, in vitro fertilization, and embryo transfer, which are essential for facilitating and controlling animal reproduction. The market's growth is fundamentally propelled by the rising global demand for superior animal protein and the imperative for genetic enhancements to boost livestock productivity and disease resistance. Furthermore, the push for sustainable breeding practices to guarantee food security is fostering widespread adoption within the dairy and beef industries.

Despite these positive growth factors, the market faces significant hurdles due to the high operational costs of advanced reproductive technologies and the need for specialized veterinary skills, which restricts accessibility for smaller producers. The economic reality often limits these sophisticated solutions to larger operations. Highlighting the sector's resilience and ongoing investment in genetic materials, the National Association of Animal Breeders reported in 2024 that the U.S. bovine semen industry saw a 4% increase in total unit sales, reaching nearly 69 million units, demonstrating continued commercial activity despite the financial barriers present in specific market segments.

Market Driver

The surging global demand for high-quality animal protein and dairy products serves as the primary engine for the veterinary assistive reproduction technology market. As population expansion places greater strain on food supply chains, producers are increasingly adopting reproductive technologies to maximize herd efficiency and overall output. This necessity fuels the broad utilization of artificial insemination and embryo transfer, methods that accelerate the dissemination of superior genetic traits to improve meat quality and milk yields. Underscoring this trend, the USDA Foreign Agricultural Service forecasted in its April 2024 report that global beef production would climb to 59.5 million tons, highlighting the urgent need for efficient breeding protocols to satisfy consumption targets.

Market development is further stimulated by the rapid integration of advanced genomic and embryonic technologies, which provide precise control over livestock characteristics. Innovations like sexed semen and genomic selection enable veterinary professionals to reduce hereditary diseases and refine herd demographics with exceptional accuracy. This move towards precision breeding is bolstered by strategic research investments; for example, the National Institute of Food and Agriculture announced a $6 million award in June 2024 to support research in quantitative genetic methods. Such technological advancements are underpinned by robust commercial performance, evidenced by Genus PLC reporting an annual revenue of £668.8 million in 2024, reflecting the substantial economic scale of the sector.

Market Challenge

The significant operational expenses linked to advanced reproductive procedures, coupled with the necessity for specialized veterinary knowledge, constitute a major obstacle to the growth of the Global Veterinary Assistive Reproduction Technology Market. These economic and technical requirements establish a tiered market landscape where adoption is principally limited to well-funded industrial integrators. Small-scale producers frequently struggle to justify the return on investment, which restricts the broad penetration of technologies like embryo transfer to elite breeding herds. Consequently, this exclusivity impedes the market from attaining mass-volume adoption throughout the wider livestock sector.

The tangible impact of these barriers is reflected in the contraction of traditional market segments that are typically more accessible to a diverse range of producer sizes. According to the International Embryo Technology Society's 2024 statistical report, the global collection of in vivo-derived cattle embryos fell by 6.3% from the prior year, with the United States specifically experiencing a sharp 29.8% decline in this category. This downward trajectory in specific procedure volumes demonstrates how persistent economic pressures and the requisite technical proficiency continue to inhibit the more extensive application of reproductive technologies within the industry.

Market Trends

The cattle breeding sector is currently experiencing a decisive structural shift from In Vivo Derived (MOET) embryo collection to In Vitro Embryo Production (IVP), motivated by the latter's capacity to optimize donor yield and utilize females across diverse physiological states. This technique enables oocyte collection from pregnant heifers and cows without disrupting gestation, thereby substantially boosting the volume of genetic material obtainable from elite stock compared to conventional flushing methods. As laboratories scale up to meet this rising demand, the American Embryo Transfer Association reported in its '2025 Statistical Information Committee Report' that the United States produced 1,037,095 in vitro produced (IVP) embryos in 2024, a 6.6% increase from the previous year, confirming IVP as the prevailing embryo production methodology.

Concurrently, the dairy industry is aggressively standardizing the usage of sexed semen to refine herd inventory management, employing gender-selected doses to generate replacement heifers while breeding the remaining herd to beef sires. This 'beef-on-dairy' strategy permits producers to hasten genetic improvement in the milking herd while producing higher-value crossbred calves for the beef market, effectively minimizing the creation of lower-value male dairy calves. This commercial trend has significantly altered sales compositions; the National Association of Animal Breeders noted in March 2025 that gender-selected dairy semen became the largest product category in the United States, reaching a volume of 9.9 million units in 2024.

Key Market Players

• Genus Plc
• URUS Group LP
• CRV Holding B.V.
• Semex USA Inc.
• Select Sires, Inc.
• Swine Genetics International Ltd.
• Inguran Sorting Technologies LLP
• Viking Genetics Fmba
• Geno SA

Report Scope

In this report, the Global Veterinary Assistive Reproduction Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Assistive Reproduction Technology Market, By Product

• Normal Semen
• Sexed Semen

Veterinary Assistive Reproduction Technology Market, By Animal Type

• Bovine
• Swine
• Ovine
• Caprine
• Equine
• Other Animals

Veterinary Assistive Reproduction Technology Market, By Conception Method

• Artificial Insemination
• Embryo transfer (MOET)
• IVF

Veterinary Assistive Reproduction Technology Market, By Distribution Channel

• Private
• Public

Veterinary Assistive Reproduction Technology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Assistive Reproduction Technology Market.

Available Customizations:

Global Veterinary Assistive Reproduction Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Assistive Reproduction Technology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Normal Semen, Sexed Semen)
  • 5.2.2. By Animal Type (Bovine, Swine, Ovine, Caprine, Equine, Other Animals)
  • 5.2.3. By Conception Method (Artificial Insemination, Embryo transfer (MOET), IVF)
  • 5.2.4. By Distribution Channel (Private, Public)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Assistive Reproduction Technology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Animal Type
  • 6.2.3. By Conception Method
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Assistive Reproduction Technology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Conception Method
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Veterinary Assistive Reproduction Technology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Conception Method
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Veterinary Assistive Reproduction Technology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Conception Method
      • 6.3.3.2.4. By Distribution Channel

7. Europe Veterinary Assistive Reproduction Technology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Animal Type
  • 7.2.3. By Conception Method
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Assistive Reproduction Technology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Conception Method
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Veterinary Assistive Reproduction Technology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Conception Method
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Veterinary Assistive Reproduction Technology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Conception Method
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Veterinary Assistive Reproduction Technology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Animal Type
      • 7.3.4.2.3. By Conception Method
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Veterinary Assistive Reproduction Technology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Animal Type
      • 7.3.5.2.3. By Conception Method
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Veterinary Assistive Reproduction Technology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Animal Type
  • 8.2.3. By Conception Method
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Assistive Reproduction Technology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Conception Method
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Veterinary Assistive Reproduction Technology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Conception Method
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Veterinary Assistive Reproduction Technology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Conception Method
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Veterinary Assistive Reproduction Technology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By Conception Method
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Veterinary Assistive Reproduction Technology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By Conception Method
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Veterinary Assistive Reproduction Technology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Animal Type
  • 9.2.3. By Conception Method
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Assistive Reproduction Technology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Conception Method
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Veterinary Assistive Reproduction Technology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Conception Method
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Veterinary Assistive Reproduction Technology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Conception Method
      • 9.3.3.2.4. By Distribution Channel

10. South America Veterinary Assistive Reproduction Technology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Animal Type
  • 10.2.3. By Conception Method
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Assistive Reproduction Technology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By Conception Method
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Veterinary Assistive Reproduction Technology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By Conception Method
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Veterinary Assistive Reproduction Technology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By Conception Method
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Assistive Reproduction Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Genus Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. URUS Group LP
• 15.3. CRV Holding B.V.
• 15.4. Semex USA Inc.
• 15.5. Select Sires, Inc.
• 15.6. Swine Genetics International Ltd.
• 15.7. Inguran Sorting Technologies LLP
• 15.8. Viking Genetics Fmba
• 15.9. Geno SA

16. Strategic Recommendations

17. About Us & Disclaimer